Walleye Trading LLC Uni Qure N.V. Call Options Transaction History
Walleye Trading LLC
- $52.6 Billion
- Q2 2025
Call Options
	  15 transactions
	
  Others Institutions Holding QURE
# of Institutions
192Shares Held
52.6MCall Options Held
4.43MPut Options Held
1.27M- 
    
      Rtw Investments, LP New York, NY5.16MShares$350 Million1.1% of portfolio
- 
    
      Eco R1 Capital, LLC San Francisco, CA3.99MShares$271 Million4.79% of portfolio
- 
    
      Vestal Point Capital, LP New York, NY3.7MShares$251 Million2.72% of portfolio
- 
    
      Avoro Capital Advisors LLC New York, NY3.63MShares$246 Million0.92% of portfolio
- 
    
      Abrdn PLC2.75MShares$187 Million0.07% of portfolio
About uniQure N.V.
- Ticker QURE
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 46,729,100
- Market Cap $3.17B
- Description
- uniQure N.V., a gene therapy company, engages in the development of treatments for patients suffering from genetic and other devastating diseases. Its lead program is Etranacogene dezaparvovec (AMT-061), which is in Phase III HOPE-B pivotal trial for the treatment of hemophilia B. The company also engages in developing AMT-130, a gene therapy th...